Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Presentations

Unlocking the Potential of PSMA Therapy: A Next Generation Portfolio Approach
ProstACT Global Part 1 Data
TLX591-Tx: Development overview and data highlights
2025 Full Year Results Presentation
Results Webcast
2026 JPM Healthcare Conference Presentation
Pipeline overview
H1 2025 Results Presentation
Telix Investor Day Presentation
Telix Investor Day Presentation
Telix Annual General Meeting Presentation
  • Current page 1
  • Page 2
  • Next page ›
  • Last page »

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors